We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.

Please complete this form to contact Sanofi Canada. All information you provide will be maintained in accordance with our privacy policy. We provide product information and cannot offer medical advice ...

Bien que le phénomène de l’aggravation associée à l’inflammation neuroinflammatoire dans la sclérose en plaques soit largement reconnu par la communauté médicale, il reste encore beaucoup à faire pour ...

The phenomenon of smoldering-associated worsening in multiple sclerosis has been widely accepted by the medical community, yet much work is needed to fully integrate it into clinical practice.

L’hémophilie est une affection rare, héréditaire, à vie dans laquelle le sang d’une personne ne coagule pas correctement en raison d’un manque de protéines appelées facteurs de coagulation. Par ...

Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, ...

Hemophilia can affect nearly every aspect of a person’s life, but these daily impacts are often overlooked, and current solutions rarely go beyond medical care. Sanofi is committed to working with the ...

Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU Confirming the results of CUPID-A, this second pivotal study in biologic-naïve patients ...

En Sanofi perseguimos el poder de la ciencia para mejorar la vida de las personas. De la mano de un equipo diverso y implicado, combinamos la ciencia y la tecnología para desarrollar tratamientos y ...

Sanofi inaugure la première usine modulable de vaccins et biomédicaments au monde à Neuville-sur-Saône Paris, le 10 septembre 2024. En présence du Président de la République, ...

ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies Pooled results from the BOREAS and NOTUS studies show meaningful clinical benefit ...

A Million Conversations is Sanofi’s global initiative to rebuild trust in healthcare with the underrepresented. Specifically with Black and ethnic minority groups, women, people with disabilities, and ...